| Symbol | SBHMY |
|---|---|
| Name | SINO BIOPHARMACEUTICAL LTD. |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | - |
| Address | Hong Kong Rm 4109, Office Tower Convention Plaza, 1 Harbour Road |
| Telephone | +852 2802 9886 |
| Fax | — |
| — | |
| Website | http://www.sinobiopharm.com |
| Incorporation | KY |
| Incorporated On | 2000 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Ernst & Young LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Hong Kong Stock Exchange |
| CIK | 0001604982 |
| Description | Sino Biopharmaceutical Limited, together with its subsidiaries, is an integrated pharmaceutical enterprise. Applying advanced biomedical technology, the Group researches, develops, manufactures and markets a vast array of modernized Chinese medicines and chemical medicines. Additional info from OTC: Additional info from NASDAQ: |
Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: SINO BIOPHARM ORD.
Read morePink Current symbol attribute type Security_Name was changed. Previous value: -. New value: SINO BIOPHARM UNSP/ADR.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: SINO BIOPHARM ORD.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: SINO BIOPHARM UNSP/ADR.
Read more